AMPAC Fine Chemicals and Codexis Enter Into a Manufacturing Partnership
Under a new agreement, AFC will partner with Codexis to use Codexis' proprietary biocatalysis technology in combination with AFC's existing technologies to reduce cost, increase manufacturing efficiency and lessen environmental impact for pharmaceutical intermediates and APIs. Through this collaboration, AFC will have access to certain Codexis biocatalysts that add to the technology "toolbox" already present at AFC. AMPAC Fine Chemicals and Codexis will focus on development of new chemical processes through this collaboration that, if successful, could result in manufacturing cost reductions on a number of marketed pharmaceutical products.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.